By Beth Baker, Next Avenue Contributor
A modest program aimed at keeping older adults independent and in their own homes is showing promising results. Dubbed CAPABLE, for Community Aging in Place, Advancing Better Living for Elders, the program, which started in the Baltimore area, saved Medicare an average of $10,000 annually in health care costs per participant during a recent two-year trial. That trial program was supported by the Centers for Medicare and Medicaid Services (CMS). A second trial will wrap up this year, funded by the National Institutes of Health.
Worth noting: This surprisingly low-budget approach to care focuses on people who are at risk of becoming disabled, but not all of the help is medical in nature. Participants set their own goals for functioning and quality of life and the program helps them improve their home environment and their ability to do needed tasks.
stock market prices today: VIVUS, Inc.(VVUS)
- [By Peter Graham]
A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:
- [By Keith Speights]
Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.
stock market prices today: Telefonica Brasil S.A.(VIV)
- [By Lisa Levin]
In trading on Wednesday, telecommunications services shares slipped by 0.08 percent. Meanwhile, top losers in the sector included Turkcell Iletisim Hizmetleri A.S. (ADR) (NYSE: TKC), down 2 percent, and Telefonica Brasil SA (ADR) (NYSE: VIV), down 2.5 percent.
- [By Sofia Horta e Costa]
Vivendi (VIV) rose 2.7 percent to 17.15 euros. Music, pay-TV, European cinema and Internet in Brazil will make up a new media group based in France after the split with phone unit SFR, according to a statement yesterday.
stock market prices today: Kalytera Therapeutics, Inc. (QUEZF)
- [By Javier Hasse]
Kalytera Therapeutics Inc (OTC: QUEZF) closed a C$13.4 million ($10.2 million) tranche of a private placement for the acquisition of Talent Biotechs Ltd.
stock market prices today: Female Health Company (The)(FHCO)
- [By Lisa Levin]
Shares of Female Health Co (NASDAQ: FHCO) were down 15 percent to $1.46 as the company reported that it has entered into a merger agreement with Aspen Park Pharma.
stock market prices today: Select Medical Holdings Corporation(SEM)
- [By Ben Levisohn]
Overvalued companies include MWI Veterinary (MWIV) andStericycle (SRCL), while companies with attractive valuations include Cardinal Health (CAH), Selected Medical (SEM). He’s not a fan of Intrexon (XON) but callsAratana (PETX) a “hidden gem.”
stock market prices today: Celanese Corporation(CE)
- [By Ben Levisohn]
Time To Favor Optionality: Most macro data are similar to, or better than, when the merger was announced. As a result, the same returns have been obtainable, with significantly less stress, simply through owning 3M (MMM) or a basket of chemical companies that approximate the Dow-DuPont portfolio. Relative to the chemical sector, performance has been average, leverage appears reasonable but near-term FCF less-than compelling partly due to new capacity ramping. With the merger likely to close in the near-term (90% chance, in our view), we believe Dow-DuPont will have an opportunity to show how scale creates optionality. The overhaul at Celanese (CE) over the past few years shows the way.
- [By Zacks]
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Albemarle Corporation (NYSE: ALB): Free Stock Analysis Report
Celanese Corporation (NYSE: CE): Free Stock Analysis Report
Kronos Worldwide Inc (NYSE: KRO): Free Stock Analysis Report
Koppers Holdings Inc. (NYSE: KOP): Free Stock Analysis Report
Chemours Company (The) (CC): Free Stock Analysis Report
Kraton Corporation (NYSE: KRA): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research